Drawing for SPARK.AI

USPTO serial 98840066

SPARK.AI

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
ALLEN, LACEY M
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SPARK.AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

RITAMBHARA CHAUHAN

RITAMBHARA CHAUHAN MY STARTUP LAWYER PLLC14850 QUORUM DRIVE, STE 21014850 QUORUM DRIVEDALLAS, TX 75254

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software using artificial intelligence (AI) for medical reporting and data management incorporating speech-to-text dictation and generative AI capabilities, downloadable via the internet, on desktop computers, and on wireless devices in the nature of mobile devices and tablets; Downloadable computer software using artificial intelligence (AI) for medical imaging, reporting and data management, featuring AI image detection algorithms for identifying abnormalities and pathologies to streamline the reporting process, downloadable via the internet, on desktop computers, and on wireless devices in the nature of mobile devices and tablets; Downloadable computer software for development and integration of artificial intelligence, deep learning, and machine learning algorithms into radiology workflows; Downloadable computer software for development and integration of artificial intelligence, deep learning, and machine learning algorithms into radiology workflowsABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 2, 2026MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Mar 2, 2026ABN4ABANDONMENT - AFTER INTER PARTES DECISION
Mar 2, 2026OP.TOPPOSITION TERMINATED NO. 999999
Mar 2, 2026OP.SOPPOSITION SUSTAINED NO. 999999
Oct 29, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 17, 2025OP.IOPPOSITION INSTITUTED NO. 999999
Jul 24, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jul 1, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 25, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 30, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2025XAECEXAMINER'S AMENDMENT ENTERED
May 30, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 30, 2025GNEAEXAMINERS AMENDMENT E-MAILED
May 30, 2025CNEAEXAMINERS AMENDMENT -WRITTEN
May 5, 2025DOCKASSIGNED TO EXAMINER
May 2, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2024NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance